Filtered By:
Specialty: Cardiology
Procedure: Coronary Artery Bypass Graft
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 758 results found since Jan 2013.
Moderate-Intensity Statins Plus Ezetimibe vs. High-Intensity Statins After Coronary Revascularization: A Cohort Study
ConclusionsPatients undergoing a coronary revascularization procedure who received moderate-intensity statins plus ezetimibe showed similar rates of major adverse cardiovascular events as patients who received high-intensity statins.
Source: Cardiovascular Drugs and Therapy - September 17, 2021 Category: Cardiology Source Type: research
Surgical strategies for severely atherosclerotic (porcelain) aorta during coronary artery bypass grafting
World J Cardiol. 2021 Aug 26;13(8):309-324. doi: 10.4330/wjc.v13.i8.309.ABSTRACTPorcelain aorta (PA) is an asymptomatic atherosclerotic disease, characterized by circumferential calcification throughout the whole perimeter of the aorta. It is seen in 2% to 9.3% of patients undergoing elective coronary artery bypass grafting (CABG) and makes manipulation of the ascending aorta impossible. It has been clearly shown that most emboli seen and detected during the CABG procedure occur during aortic cross-clamping and aortic side-clamping. Manipulation of porcelain or a severely atherosclerotic aorta increases the risk of periope...
Source: World Journal of Cardiology - September 30, 2021 Category: Cardiology Authors: Gokce Sirin Source Type: research
Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG
Conclusions: In REDUCE-IT patients with a history of CABG, treatment with icosapent ethyl was associated with significant reductions in first and recurrent ischemic events.PMID:34710343 | DOI:10.1161/CIRCULATIONAHA.121.056290
Source: Circulation - October 28, 2021 Category: Cardiology Authors: Subodh Verma Deepak L Bhatt Ph Gabriel Steg Michael Miller Eliot A Brinton Terry A Jacobson Nitish K Dhingra Steven B Ketchum Rebecca A Juliano Lixia Jiao Ralph T Doyle Craig Granowitz C Michael Gibson Duane Pinto Robert P Giugliano Matthew J Budoff R Pre Source Type: research
Treatment of chronic total occlusion with percutaneous coronary intervention is associated with improved survival as compared to medical treatment alone: insights from a single-centre registry
Rev Cardiovasc Med. 2021 Dec 22;22(4):1629-1632. doi: 10.31083/j.rcm2204169.ABSTRACTSymptom relief is currently the main indication to perform percutaneous coronary intervention (PCI) of chronic total occlusion (CTO). So far, none of the randomized trials for CTO treatment have demonstrated improved survival after PCI compared to optimal medical treatment (OMT) alone. We investigated whether CTO PCI in addition to OMT could improve survival over OMT alone. Data of 1004 patients with a treated CTO was analysed. Patients with acute coronary syndrome and who underwent coronary artery bypass graft surgery (CABG) were excluded,...
Source: Reviews in Cardiovascular Medicine - December 27, 2021 Category: Cardiology Authors: Povilas Budrys Vilhelmas Bajoras Michael Rees Ieva Marija Saule Giedrius Davidavicius Andrius Berukstis Arvydas Baranauskas Source Type: research
